SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells

Mitsuro Kanda(Nagoya University), Haruyoshi Tanaka(Nagoya University), Dai Shimizu(Nagoya University), Takashi Miwa(Nagoya University), Shinichi Umeda(Nagoya University), Chie Tanaka(Nagoya University), Daisuke Kobayashi(Nagoya University), Norifumi Hattori(Nagoya University), Masaya Suenaga(Nagoya University), Masamichi Hayashi(Nagoya University), Naoki Iwata(Nagoya University), Suguru Yamada(Nagoya University), Michitaka Fujiwara(Nagoya University), Yasuhiro Kodera(Nagoya University)

Oncogene

May 30, 2018

10.1038/s41388-018-0335-8

Cited by 101

Abstract

Related Papers

Molecular mechanisms of epithelial–mesenchymal transition

Samy Lamouille, Jian Xu, Rik Derynck|Nature Reviews Molecular Cell Biology|2014|8.1k

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Yung‐Jue Bang, Eric Van Cutsem, A. Feyereislova et al.|The Lancet|2010|7.3k

Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

Mitsuru Sasako, Shinichi Sakuramoto, Hitoshi Katai et al.|Journal of Clinical Oncology|2011|1.5k

Molecular Basis of Metastasis

Anne C. Chiang, Joan Massagué|New England Journal of Medicine|2008|1.1k

The Role of Snail in EMT and Tumorigenesis

Yifan Wang, Jian Shi, Kequn Chai et al.|Current Cancer Drug Targets|2013|883